Supreme Court Faces Swift New Abortion Test With Mifepristone Case

Justice Department poised to ask high court to preserve access to widely used abortion pill

The mifepristone case is the latest aftershock of the Supreme Court’s 2022 decision overruling Roe v. Wade.Photo: ELIZABETH FRANTZ/REUTERS

WASHINGTON—The Biden administration was expected as soon as Friday to ask the Supreme Court to restore full access to the abortion pill mifepristone after lower courts restricted use of the medication, which the Food and Drug Administration first approved in 2000 and since 2016 relaxed special regulations for its prescription.

A late Wednesday order from the Fifth U.S. Circuit Court of Appeals in New Orleans rolled back mifepristone access to the pre-2016 regulations, which limited its use to women pregnant for seven or fewer weeks, required three in-person doctor visits to receive and barred sending to patients through the mail.

What's News

Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Continue reading your article with
a WSJ subscription

Subscribe Now

Already a subscriber? Sign In

Sponsored Offers